HK1065953A1 - The use of antigestagens in manufacturing a medicament for inhibiting the occurrence of advanced endometrium maturation in a female mammal - Google Patents
The use of antigestagens in manufacturing a medicament for inhibiting the occurrence of advanced endometrium maturation in a female mammalInfo
- Publication number
- HK1065953A1 HK1065953A1 HK04108894A HK04108894A HK1065953A1 HK 1065953 A1 HK1065953 A1 HK 1065953A1 HK 04108894 A HK04108894 A HK 04108894A HK 04108894 A HK04108894 A HK 04108894A HK 1065953 A1 HK1065953 A1 HK 1065953A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antigestagens
- medicament
- inhibiting
- occurrence
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75628601A | 2001-01-09 | 2001-01-09 | |
| US09/801,925 US20020143000A1 (en) | 2001-01-09 | 2001-03-09 | Use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
| PCT/IB2002/001764 WO2002067910A2 (en) | 2001-01-09 | 2002-01-09 | The use of antigestagens for inhibiting accelerated endometrial maturation during infertility treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1065953A1 true HK1065953A1 (en) | 2005-03-11 |
Family
ID=27116200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04108894A HK1065953A1 (en) | 2001-01-09 | 2004-11-11 | The use of antigestagens in manufacturing a medicament for inhibiting the occurrence of advanced endometrium maturation in a female mammal |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040152684A1 (hr) |
| EP (1) | EP1365765B1 (hr) |
| JP (1) | JP2004520411A (hr) |
| CN (1) | CN1244329C (hr) |
| AR (1) | AR032390A1 (hr) |
| AT (1) | ATE367817T1 (hr) |
| AU (1) | AU2002253488B2 (hr) |
| BG (1) | BG107977A (hr) |
| BR (1) | BR0206367A (hr) |
| CA (1) | CA2433776A1 (hr) |
| CZ (1) | CZ20031864A3 (hr) |
| DE (1) | DE60221359T2 (hr) |
| DK (1) | DK1365765T3 (hr) |
| EE (1) | EE200300321A (hr) |
| ES (1) | ES2290284T3 (hr) |
| HK (1) | HK1065953A1 (hr) |
| HR (1) | HRP20030628A2 (hr) |
| HU (1) | HUP0302632A2 (hr) |
| IL (1) | IL156729A0 (hr) |
| MX (1) | MXPA03006156A (hr) |
| NO (1) | NO20033125L (hr) |
| NZ (1) | NZ526908A (hr) |
| PL (1) | PL361689A1 (hr) |
| SK (1) | SK8612003A3 (hr) |
| WO (1) | WO2002067910A2 (hr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102009034362A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) * | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| US20130029953A1 (en) * | 2011-07-28 | 2013-01-31 | Klaus Nickisch | Progesterone antagonists |
| ES2716862T3 (es) * | 2014-12-22 | 2019-06-17 | Ferring Bv | Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida |
| EP3214092A1 (en) | 2016-03-04 | 2017-09-06 | Bayer Pharma Aktiengesellschaft | Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3533175A1 (de) * | 1985-09-13 | 1987-03-19 | Schering Ag | Antigestagene zur verschiebung der endometrialen reifung |
| DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
| DE19860719A1 (de) * | 1998-12-23 | 2000-06-29 | Schering Ag | Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen |
-
2002
- 2002-01-09 MX MXPA03006156A patent/MXPA03006156A/es unknown
- 2002-01-09 CA CA002433776A patent/CA2433776A1/en not_active Abandoned
- 2002-01-09 BR BR0206367-0A patent/BR0206367A/pt not_active IP Right Cessation
- 2002-01-09 AT AT02722637T patent/ATE367817T1/de not_active IP Right Cessation
- 2002-01-09 DK DK02722637T patent/DK1365765T3/da active
- 2002-01-09 HU HU0302632A patent/HUP0302632A2/hu unknown
- 2002-01-09 SK SK861-2003A patent/SK8612003A3/sk unknown
- 2002-01-09 EP EP02722637A patent/EP1365765B1/en not_active Expired - Lifetime
- 2002-01-09 CN CNB028061462A patent/CN1244329C/zh not_active Expired - Fee Related
- 2002-01-09 WO PCT/IB2002/001764 patent/WO2002067910A2/en not_active Application Discontinuation
- 2002-01-09 AU AU2002253488A patent/AU2002253488B2/en not_active Ceased
- 2002-01-09 CZ CZ20031864A patent/CZ20031864A3/cs unknown
- 2002-01-09 AR ARP020100053A patent/AR032390A1/es unknown
- 2002-01-09 PL PL36168902A patent/PL361689A1/xx not_active Application Discontinuation
- 2002-01-09 IL IL15672902A patent/IL156729A0/xx unknown
- 2002-01-09 ES ES02722637T patent/ES2290284T3/es not_active Expired - Lifetime
- 2002-01-09 NZ NZ526908A patent/NZ526908A/en unknown
- 2002-01-09 DE DE60221359T patent/DE60221359T2/de not_active Expired - Fee Related
- 2002-01-09 JP JP2002567278A patent/JP2004520411A/ja active Pending
- 2002-01-09 EE EEP200300321A patent/EE200300321A/xx unknown
-
2003
- 2003-07-08 BG BG107977A patent/BG107977A/bg unknown
- 2003-07-08 NO NO20033125A patent/NO20033125L/no not_active Application Discontinuation
- 2003-08-04 HR HR20030628A patent/HRP20030628A2/hr not_active Application Discontinuation
- 2003-12-30 US US10/747,060 patent/US20040152684A1/en not_active Abandoned
-
2004
- 2004-11-11 HK HK04108894A patent/HK1065953A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE367817T1 (de) | 2007-08-15 |
| CA2433776A1 (en) | 2002-09-06 |
| BR0206367A (pt) | 2003-12-23 |
| JP2004520411A (ja) | 2004-07-08 |
| SK8612003A3 (en) | 2004-03-02 |
| EP1365765A2 (en) | 2003-12-03 |
| EP1365765B1 (en) | 2007-07-25 |
| HRP20030628A2 (en) | 2005-06-30 |
| US20040152684A1 (en) | 2004-08-05 |
| MXPA03006156A (es) | 2003-09-16 |
| CN1244329C (zh) | 2006-03-08 |
| WO2002067910A2 (en) | 2002-09-06 |
| DE60221359D1 (de) | 2007-09-06 |
| BG107977A (bg) | 2004-08-31 |
| NO20033125D0 (no) | 2003-07-08 |
| WO2002067910A3 (en) | 2003-02-06 |
| AR032390A1 (es) | 2003-11-05 |
| AU2002253488B2 (en) | 2007-02-15 |
| ES2290284T3 (es) | 2008-02-16 |
| NO20033125L (no) | 2003-09-09 |
| DE60221359T2 (de) | 2008-04-17 |
| HUP0302632A2 (hu) | 2003-11-28 |
| IL156729A0 (en) | 2004-02-08 |
| DK1365765T3 (da) | 2007-10-29 |
| CZ20031864A3 (en) | 2004-03-17 |
| CN1496263A (zh) | 2004-05-12 |
| EE200300321A (et) | 2003-10-15 |
| PL361689A1 (en) | 2004-10-04 |
| NZ526908A (en) | 2005-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0108448D0 (en) | Protective hardmask for producing interconnect structures | |
| HK1102221A1 (en) | Vaginally administered anti-dysrhythmic agents for treating uterine dysrhythimia | |
| IL155442A0 (en) | Medicament dispenser | |
| HK1056125A1 (zh) | 藥劑分配器 | |
| AU4765701A (en) | Molds for making ophthalmic devices | |
| HK1038439A1 (zh) | 半導體器件及其制造方法 | |
| HK1060566A1 (en) | Anticholinergic agents that can be used as medicaments and method for the production thereof | |
| GB0130284D0 (en) | Medicament dispenser | |
| HUP0302553A3 (en) | Salts of a isothiazole-4-carboxamide and process for their preparation and use for the preparation of anti-hyperproliferation agents | |
| GB0025092D0 (en) | Medicament dispenser | |
| IL160780A0 (en) | USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT | |
| HK1065700A1 (en) | Use of gnrh antagonists in the preparation of a medicament for preventing diabetes | |
| GB0031176D0 (en) | Medicament dispenser | |
| HUP0201336A3 (en) | The use of nmda antagonist compounds for producing medicaments useful for prophylaxis of dyskinesias | |
| HK1065953A1 (en) | The use of antigestagens in manufacturing a medicament for inhibiting the occurrence of advanced endometrium maturation in a female mammal | |
| GB0011807D0 (en) | Formulation for inhalation | |
| IL160781A0 (en) | Use of lh in the manufacture of a medicament | |
| IL160782A0 (en) | USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT | |
| IL160371A0 (en) | A new extended release oral dosage form | |
| IL155431A0 (en) | Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders | |
| AU1602902A (en) | A combination comprising camptothecin and a stilbene derivative for the treatment of cancer | |
| AP2001002234A0 (en) | Crystalline therapeutic agent | |
| GB0022922D0 (en) | Compounds for use in medicine | |
| IL160372A0 (en) | A new extended release oral dosage form | |
| SI1283845T1 (en) | Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100109 |